Jingqi Jiang

A Novel FGFR3‐Targeting Antibody‐Drug Conjugate Induces Tumor Cell Apoptosis through the cGAS–STING Pathway in Bladder Cancer

Shu Qin Cui, Xiong-Fei Luo, Guangrui Fan, Jingqi Jiang et autres

Antibody-drug conjugates (ADCs) emerge as a potent cancer therapeutic strategy by enabling precise antigen recognition and efficient intracellular delivery of cytotoxic payloads. In this study, 7-ethyl-9-fluorocamptothecin (A2), a camptothecin derivative, which demonstrates potent tumor-suppressive effects across cellular models, patient-derived organoids (PDOs), and …

cn, us (code pays fourni par la source)

Deep learning 3D super-resolution radiomics model based on Gd-enhanced MRI for improving preoperative prediction of HCC pathological grading

Fei Jia, Baolin Wu, Zhuo Wang, Jingqi Jiang et autres

cn (code pays fourni par la source)

MRI-Based Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy in Nasopharyngeal Carcinoma

Zhuo Wang, Jing Zhang, Fei Jia, Jingqi Jiang

Motivation: Radiomics, as a non-invasive way for analysis of tumor heterogeneity, has been applied to the detection of therapeutic sensibility with satisfactory outcomes. Goal(s): This study aimed to explore the predictive value of nomogram combing MRI-based radiomics and clinical factors in detecting …

Efficacy and safety of triple or dual therapies for metastatic hormone-sensitive prostate cancer: a systematic review and Bayesian network meta-analysis

Jingqi Jiang, Yuhan Wang, Jiangtao Bai, Gaoyang Yang et autres

Aim: To compare triple and dual therapies for efficacy and safety in metastatic hormone-sensitive prostate cancer (mHSPC). Methods: A Bayesian network meta-analysis was conducted to indirectly compare overall survival, progression-free survival and adverse events in mHSPC patients with triple and dual therapies. …

cn, us (code pays fourni par la source)